Tecogen Receives Order for 900 Tons of Tecochill at New York Hospital
July 29 2021 - 11:00AM
via NewMediaWire -- Tecogen Inc. (OTCQX: TGEN), a
clean energy company providing ultra-efficient and clean on-site
power, heating, and cooling equipment, is pleased to announce an
order for three 200-ton Tecochill systems and one 300-ton Tecochill
system for a hospital outside of New York City. The new
chiller plant will replace an existing 750-ton Tecochill plant that
has reached the end of its intended life. The new 900-ton
chiller plant will provide additional heat recovery to the facility
along with upgraded emissions controls and refrigerant technology.
The new system is expected to be operational by the summer of 2022.
“For over 20 years the existing Tecochill plant
provided significant utility savings to this hospital,” said
Jeffrey Glick, Tecogen’s Vice President of East Coast Sales.
“When the time came to upgrade the facility with current
refrigerants, the hospital took the opportunity to expand the size
of the chiller plant by an additional 150 tons and upgrade the
plant to include Tecogen’s near-zero Ultera emissions reduction
system. The new chiller plant will also serve additional
loads on the campus to improve both the savings to the hospital and
the greenhouse gas (GHG) benefits of the facility.”
Hospitals are an ideal application for Tecochill
due to their simultaneous need for heating and cooling during
critical summer months when grid cost, capacity, and GHG profile
are more problematic. By removing the cooling load from the
electric utility and utilizing the free waste heat, hospitals can
make significant reductions in their energy costs and GHG emissions
while also reducing the need for standby generation during grid
outages.
“We are excited to upgrade this hospital with a
new chiller plant that will not only increase its energy savings,
but also support the hospital’s Environmental, Social, and
Governance (ESG) goals,” added Benjamin Locke, Tecogen’s CEO.
“Hospitals face numerous challenges regarding energy costs and
mandated emissions reductions. The Tecochill solution is an
elegant and cost-effective way to meet both energy savings goals
and carbon reduction mandates.”
About TecogenTecogen Inc. designs,
manufactures, installs, and maintains high efficiency and
ultra-clean cogeneration products, including combined heat and
power systems, air conditioning systems, and high-efficiency water
heaters for residential, commercial, recreational, and industrial
applications. The company’s cost efficient, reliable, and
environmentally friendly products for energy production nearly
eliminate criteria pollutants and significantly reduce customers’
carbon footprint.
In business for over 35 years, Tecogen has shipped
more than 3,000 units, supported by an established network of
engineering, sales, and service personnel throughout North America.
Aggregate run hours on Tecogen’s InVerde cogeneration systems
exceeds 5 million hours. For more information, please
visit www.tecogen.com or contact us for a
free Site Assessment.
Tecogen, InVerde e+, Ilios, Tecochill, Tecofrost,
Tecopack, Tecopower, and Ultera are pending or registered
trademarks of Tecogen Inc.
Forward Looking Statements
This press release contains “forward-looking
statements” which may describe strategies, goals, outlooks or other
non-historical matters, or projected revenues, income, returns or
other financial measures, that may include words such as "believe,"
"expect," "anticipate," "intend," "plan," "estimate," "likely"
or "may" and similar expressions intended to identify
forward-looking statements. These statements are only predictions
and involve known and unknown risks, uncertainties and other
factors that may cause our actual results to differ materially from
those expressed or implied by such forward-looking statements.
Forward-looking statements speak only as of the date on which they
are made, and we undertake no obligation to update or revise any
forward-looking statements.
In addition to the Risk Factors described in our
Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q
under “Risk Factors,” factors that could cause our actual results
to differ materially from past and projected future results include
the impact of the coronavirus pandemic on demand for our products
and services, the availability of incentives, rebates and tax
benefits relating to our products, changes in the regulatory
environment relating to our products, competing technological
developments, and the availability of financing to fund our
operations and growth.
Tecogen Media & Investor Relations Contact
Information:
Benjamin Locke, CEO
P: (781) 466-6402
E: Benjamin.Locke@Tecogen.com
Tecogen (NASDAQ:TGEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tecogen (NASDAQ:TGEN)
Historical Stock Chart
From Sep 2023 to Sep 2024